Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Current Treatment Options in Oncology

Issue 8/2016

Content (6 Articles)

Lower Gastrointestinal Cancers (AB Benson, Section Editor)

Deficient Mismatch Repair and the Role of Immunotherapy in Metastatic Colorectal Cancer

Dionisia Quiroga, H. Kim Lyerly, Michael A. Morse

Upper Gastrointestinal Cancers (L Rajdev, Section Editor)

Advanced Hepatocellular Cancer: the Current State of Future Research

Louise C. Connell, James J. Harding, Ghassan K. Abou-Alfa

Gynecologic Cancers (RJ Morgan, Section Editor)

Current Strategy for the Treatment of Ovarian Germ Cell Tumors: Role of Extensive Surgery

Jin Li, Xiaohua Wu

Gynecologic Cancers (RJ Morgan, Section Editor)

Health Care Disparities in Hereditary Ovarian Cancer: Are We Reaching the Underserved Population?

Thomas C. Randall, Katrina Armstrong

Neuro-oncology (GJ Lesser, Section Editor)

Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future

Ricky Chen, Adam L. Cohen, Howard Colman

Head and Neck Cancer (J-P Machiels, Section Editor)

Checkpoint Inhibitors in Head and Neck Cancer: Rationale, Clinical Activity, and Potential Biomarkers

Panagiota Economopoulou, Ioannis Kotsantis, Amanda Psyrri

Jul 16
Issue: 7/2016
Sep 16
Issue: 9/2016

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits